Fund HoldingsDarwin Global Management, Ltd.

Total Portfolio Value
$859.47M
Total Bought
$638.00M
Total Sold
$477.12M
Net Transaction
+$160.88M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
CYTOKINETICS INC(CYTK)04,575,558+4,575,5580246,07428.63%+246,074
INSMED INC(INSM)03,541,095+3,541,0950237,07627.58%+237,076
GERON CORP(GERN)023,915,480+23,915,4800106,18512.35%+106,185
CORBUS PHARMACEUTICALS HLDGS0325,140+325,140014,2671.66%+14,267
AVIDITY BIOSCIENCES INC0200,000+200,00008,1080.94%+8,108
ELEVATION ONCOLOGY INC2,332,9281,916,290-416,63811,9684,8100.56%-7,158
SPYRE THERAPEUTICS INC(SYRE)473,200452,040-21,16017,94810,2661.19%-7,683
MERCK & CO INC(MRK)79,6000-79,60010,5030-10,503
TOURMALINE BIO INC465,0000-465,00010,6490-10,648
VAXCYTE INC(PCVX)2,750,8042,080,946-669,858187,907163,91619.07%-23,991
XENCOR INC(XNCR)1,109,6500-1,109,65024,5570-24,557
KEROS THERAPEUTICS INC1,435,9501,525,902+89,95295,06068,7728.00%-26,287
APOGEE THERAPEUTICS INC(APGE)832,1980-832,19855,3000-55,300
BEAM THERAPEUTICS INC(BEAM)2,119,5980-2,119,59870,0320-70,032
ALPINE IMMUNE SCIENCES INC1,982,0160-1,982,01678,5670-78,567
BIOHAVEN LTD(BHVN)1,476,9740-1,476,97480,7760-80,776
NUVALENT INC(NUVL)1,436,9640-1,436,964107,9020-107,902
Page 1 of 1